Indeed, other than phosphorylating p62 promoting KEAP1 sequestration [138], its inhibition in RCC cells induces both p62 and NRF2 but prevents its nuclear translocation through GSK-3β activation [139], further supporting mTOR involvement in NRF2 activation in RCC. The gene discussed is MTOR; the disease is renal cell carcinoma.